MPTP-Induced Hemiparkinsonism in Nonhuman Primates 6–8 Years after a Single Unilateral Intracarotid Dose
- 31 August 1998
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 152 (2), 214-220
- https://doi.org/10.1006/exnr.1998.6845
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Estrogen Alters MPTP‐Induced Neurotoxicity in Female Mice: Effects on Striatal Dopamine Concentrations and ReleaseJournal of Neurochemistry, 1996
- Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indicesAnnals of Neurology, 1993
- In vivo imaging of monoaminergic nerve terminals in normal and MPTP‐lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazineSynapse, 1993
- Positron emission tomography with 18F-DOPA: Interpretation and biological correlates in nonhuman primatesPsychiatry Research: Neuroimaging, 1992
- Oral levodopa dose‐response study in MPTP‐induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonismMovement Disorders, 1991
- The role of environmental toxins in the etiology of Parkinson's diseaseTrends in Neurosciences, 1989
- Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinNeuropharmacology, 1989
- Older dopaminergic neurons do not recover from the effects of MPTPNeuropharmacology, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983